Androstenediol dipropionate

Source: Wikipedia, the free encyclopedia.
Androstenediol dipropionate
Clinical data
Trade namesBisexovis, Bisexovister, Ginandrin, Stenandiol
Other names5-Androstenediol 3β,17β-dipropionate; Androst-5-ene-3β,17β-diol 3β,17β-dipropionate
Routes of
administration
Intramuscular injection
Drug classAndrogen; Anabolic steroid; Androgen ester
Identifiers
  • [(3S,8R,9S,10R,13S,14S,17S)-10,13-Dimethyl-17-propanoyloxy-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] propanoate
JSmol)
  • CCC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC[C@@H]4OC(=O)CC)C)C
  • InChI=1S/C25H38O4/c1-5-22(26)28-17-11-13-24(3)16(15-17)7-8-18-19-9-10-21(29-23(27)6-2)25(19,4)14-12-20(18)24/h7,17-21H,5-6,8-15H2,1-4H3/t17-,18-,19-,20-,21-,24-,25-/m0/s1
  • Key:ZDDFOEZPFDWEQS-YMKPZFJOSA-N

Androstenediol dipropionate (brand names Bisexovis, Bisexovister, Ginandrin, Stenandiol), or 5-androstenediol 3β,17β-dipropionate, also known as androst-5-ene-3β,17β-diol 3β,17β-dipropionate, is a

5-androstenediol (androst-5-ene-3β,17β-diol) – which has been marketed in Europe, including in Spain, Italy, and Austria.[1][2][3][4][5]

See also

References